adamantane has been researched along with Carcinoma, Non-Small Cell Lung in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dastmalchi, S; Hasanifard, L; Karimi, P; Rashtchizadeh, N; Samadi, N | 1 |
| Dai, L; Foroozesh, M; Miele, L; Qin, Z; Smith, CD | 1 |
| Hong, LY; Luo, M; Mai, L; Wu, JJ; Yang, JH | 1 |
| Li, Z; Mei, Z; Shi, L; Shi, M; Sun, S; Wang, Y; Wang, Z; Xie, C; Yang, C; Yang, J; Zhang, S | 1 |
| Fer, ND; Monks, A; Shoemaker, RH | 1 |
| Hong, WK; Lotan, R; Shroot, B; Sun, SY; Yue, P | 1 |
6 other study(ies) available for adamantane and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Sphingosine kinase-2 Inhibitor ABC294640 Enhances Doxorubicin-Induced Apoptosis of NSCLC Cells via Altering Survivin Expression.
Topics: A549 Cells; Adamantane; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Phosphotransferases (Alcohol Group Acceptor); Protein Kinase Inhibitors; Pyridines; Survivin; Tetradecanoylphorbol Acetate | 2018 |
The sphingosine kinase 2 inhibitor ABC294640 displays anti-non-small cell lung cancer activities in vitro and in vivo.
Topics: A549 Cells; Adamantane; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Growth Processes; Ceramides; Humans; Lung Neoplasms; Mice; Phosphotransferases (Alcohol Group Acceptor); Protein Kinase Inhibitors; Pyridines; Random Allocation; Xenograft Model Antitumor Assays | 2018 |
The combination therapy of HIF1α inhibitor LW6 and cisplatin plays an effective role on anti-tumor function in A549 cells.
Topics: A549 Cells; Acetanilides; Adamantane; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Inhibitory Concentration 50; Lung Neoplasms | 2019 |
ABC294640, a sphingosine kinase 2 inhibitor, enhances the antitumor effects of TRAIL in non-small cell lung cancer.
Topics: Adamantane; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Molecular Targeted Therapy; Phosphotransferases (Alcohol Group Acceptor); Protein Kinase Inhibitors; Protein Transport; Pyridines; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand | 2015 |
Adaphostin toxicity in a sensitive non-small cell lung cancer model is mediated through Nrf2 signaling and heme oxygenase 1.
Topics: Adamantane; Biomarkers, Tumor; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Nucleus; Cell Proliferation; Enzyme Activation; Fluorescent Antibody Technique; Gene Expression Profiling; Heme Oxygenase-1; Humans; Hydroquinones; Lung Neoplasms; NF-E2-Related Factor 2; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Protein Transport; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tumor Cells, Cultured | 2010 |
Induction of apoptosis in human non-small cell lung carcinoma cells by the novel synthetic retinoid CD437.
Topics: Adamantane; Apoptosis; Benzoates; Carcinoma, Non-Small-Cell Lung; Cell Division; Humans; Lung Neoplasms; Receptors, Retinoic Acid; Retinoids; Transcription Factor AP-1; Tumor Cells, Cultured | 1997 |